All In MedTech

Device Trial Radar · NCT06553625

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 29, 2024

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Aug 14, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Conditions

  • Parkinson Disease
  • Dystonia
  • Essential Tremor
  • Movement Disorders

Interventions

  • Radiofrequency AblationDevice

    Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in patient's quality of life (QoL) during the study as compared with baselineTime frame: Up to 24-Months

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Uniklinik Köln

    Cologne, Germany · Recruiting

  • Universitaetsklinikum Dusseldorf

    Düsseldorf, Germany · Recruiting

  • Universitaetsklinikum Wuerzburg

    Würzburg, Germany · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.